Gelucire 5013 Structure

Purpose.To evaluate the ability of Gelucire 50/13 (an amphiphilic lipid excipient) to act as a stabilizer for lipid nanocarriers such as solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) and to establish the ability of Gelucire 50/13 based lipid nanocarriers to improve oral delivery of hydrophobic drugs using repaglinide (RPG) as a model drug.

Gelucire 5013 structure. It melts at approximately 50°C and has hydrophilic-lipophilic balance (HLB) value of 13 6, 7. Lauryl macrogol-32 glycerides (Gelucire 44/14) or stearoyl macrogol-32 glycerides (Gelucire 50/13). The present paper reports on physical and thermal properties of polyoxyethylene glycol glycerides (Gelucire 50/13) used as sustained release matrix forming agent in pharmaceutical applications.

Application Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF, Matrix for modified release, Multiparticulates;. Solid dispersion (SD) system of everolimus (EVR) with Gelucire 50/13 (Stearoyl polyoxyl-32 glycerides) was prepared using melt granulation technique with the aim of improving the physicochemical properties and dissolution rate. • For the first time, we have assigned all vibrational modes of the Gelucire 50/13.

In this work, the utilization of a spray‐congealing technique using a new ultrasonic atomizer to prepare enhanced‐release, solvent‐free microspheres of carbamazepine (CBZ)–Gelucire 50/13 in different drug‐to‐polymer ratios was considered. According to differential scanning calorimetry and powder X-ray diffractometry analysis, MX was. At last,Gelucire 50-13(-05-8) safety, risk, hazard.

Gelucire 50/13 is a mixture of mono-, di-, and triglycerides and mono-, diacyl polyethylene glycols. Curcumin was dissolved in Gelucire 50/13 stearoyl polyethylene glycol (32) glycerides and was stabilized with either Gelucire 50/13 or Pluronic F127. The purpose of this research was to develop and optimize a controlled-release multiunit floating system of a highly water soluble drug, ranitidine HCl, using Compritol, Gelucire 50/13, and Gelucire 43/01 as lipid carriers.

ChemicalBook provide Chemical industry users with gelucire 44-14 Boiling point Melting point,gelucire 44-14 Density MSDS Formula Use,If You also need to gelucire 44-14 Other information,welcome to contact us. A polyglycolised glyceride lipid carrier, Gelucire 50/13 (G50/13) was used to develop sustained release capsules while high viscosity grade HPMC was used to form sustained release tablets of. In this work, solid dispersions with Gelucire 50/13 and silicon dioxide, a drying adjuvant, have been generated as an approach to enhance the lipophilic molecule ursolic acid (UA) dissolution profile, for which low bioavailability limits its therapeutic potential.

Here you can get chemical information (such as chemical physical properties, safety data, Excellent china suppliers and their web addresses and etc.)by searching the name, CAS number, molecular formula, molecular weight, MDL number, EINECS number, structure. The dissolution rate of EVR from the optimized SD composed of the drug, Gelucire 50/13 and microcrystalline cellulose in a weight ratio of 1:5:10, was markedly rapid and higher than that from the drug powder and the market product (Afinitor ®, Novartis Pharmaceuticals) in all dissolution mediums tested from pH 3.0 to pH 6.8. Transition at 36°C to its most stable form.

Subscribe to New Research on Gelucire 50-13. Its chemical name is Stearoyl macrogol-32 glycerides. (Gelucirefi 50/13 and Gelucire.

Structure of the main compounds. Main components of Gelucire® 50/13. Amin, Shalam Mohamed Hussain.

The bioavailability of another HIV protease inhibitor, ritonavir, was also substantially enhanced, relative to a conventional formulation, by using a solid dispersion formulation prepared from a mixture of Gelucire 50/13, polysorbate 80 and polyoxyl 35 castor oil (32). The PEG and PEG esters presenting a solid phase. Gelucire® 50/13 is a stearoyl polyoxyl/macrogol 32 glycerides NF/EP and consists of mono, di- and triglycerides and PEG-32 (MW 1500) mono- and diesters of palmitic (C16) and stearic (C18) acids.

Ranitidine HCl-lipid granules were prepared by the melt granulation technique and evaluated for in vitro floating and drug release. Structure of the final systems and there is a limited understanding of how drug-carrier physical states influence the overall performance of Gelucires-based dispersions produced by spray congealing. Gelucires are defined by their melting point/HLB value.

Formulations containing Gelucire 50/13 and Compritol 8 alone failed to float. Its hydrophilic property and low melting point makes it a good choice for use as carrier in preparation of solid dispersions by fusion method (Eloy et al., 12). 0 relevant articles (0 outcomes, 0 trials/studies) Bio-Agent Context:.

Self-emulsifies in aqueous media forming a fine dispersion, i.e., microemulsion (SMEDDS). Suppliers List, E-mail/RFQ Form, Molecular Structure, Weight, Formula, IUPAC, Synonyms for GELUCIRE 50-13 (CAS No. The hydration behavior of this amphiphilic excipient has been investigated.

Functionality Solubilizer for poorly-soluble APIs and bioavailability enhancer. USD $ 0.0-0.0/ 1.Our services：A.Supply sampleB.The packing also can be according the customers` requirmentC.Any inquiries will be replied within 24 hoursD.we provide Commerical Invoice, Packing List, Bill of loading, COA , Health certificate and Origin certificate. The purpose of this research was to develop and optimize a controlled-release multiunit floating system of a highly water soluble drug, ranitidine HCl, using Compritol, Gelucire 50/13, and Gelucire 43/01 as lipid carriers.

• Vibrational behavior of Gelucire according to the temperature and degree of hydration. It is able to self-emulsify on contact with aqueous media forming a fine dispersion i.e. Gelucire ® 50/13 It is a non-ionic, water dispersible surfactant composed of well-characterized PEG-esters, a small glyceride fraction and free PEG.

The cubic mesophases do not melt until the temperature exceeds 40 degrees C. Developed to melt within specific ranges. Josimar de Oliveira Eloy, Juliana Saraiva, Sergio de Albuquerque, Juliana Maldonado Marchetti.

13studied the effect of Gelucire 50/13 on disso-. Drug release profiles of SBL release by using G50/13 and its blends with other hydrophilic or hydrophobic materials were investigated. Pronunciation of Gelucire with 2 audio pronunciations and more for Gelucire.

Visit ChemicalBook To find more Gelucire 50-13(-05-8) information like chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight, physical properties,toxicity information,customs codes. Ranitidine HCl-lipid granules. The effect of incorporating caffeine and paracetamol on the structure and behaviour of Gelucire 50/13 has been studied with a view to establishing whether the choice of drug influences the solid structure and release mechanism.

Laboratory of Condensed Matter Physics, Abdelmalek Essaâdi University, Tetouan, Morocco. The dissolution of poorly water soluble drugs may be significantly enhanced in a solid dispersion with hydrophilic lipid excipients, such as Gelucire 50/13 (85), Gelucire 44/14 (,93) compared to. Gelucire containing only glycerides or a mixture of glycerides and PEG esters (Gelucire 39/01, 43/01) are used in the preparation of sustained release formulation.

The results of. Hydrophilicity and low density, Gelucire 50/13 may be considered an appropriate carrier for designing fast release floating drug delivery system11. Gelucire® 50/13 (stearoyl polyoxyl-32 glycerides) is a nonionic water-dispersible surfactant for lipid-based formulations to solubilize and increase oral bioavailability of poorly water-soluble APIs.

The ability of Gelucire 50/13 to nanosize various solid lipids was evaluated. The study describes the application of a spray‐congealing technique, using a new ultrasound‐assisted atomizer to prepare microparticles of diclofenac/Gelucire 50/13, with the aim to obtain a formulation of enhanced‐release, at 10% w/w drug‐to‐excipient ratio, without any employ of solvent. Gelucire 50/13 is a semisolid excipient with an HLB value of 13 and melting point of 500C.

AAPS PharmSciTech Solid dispersion of ursolic acid in Gelucire 50/13:. At body temperature, all crystals in Gelucire 44/14 melt to an isotropic fluid as soon as the total water content exceeds 5%. Single excipient formulation system:.

Gelucire 50/13 is an excipient composed of fatty acid (C16 and C18) esters of glycerol, PEG esters and free PEG. Spherical microparticles were yielded with smooth surfaces as observed by scanning electron microscopy. SLNs consist of a solid lipid core matrix where a drug is solubilized.

Dispersions containing up to 30% w/w drug were prepared and studied using differential scanning calorimetry (DSC), hot. Gelucire 44/14 forms a lamellar phase and this phase melts at 30 degrees C whereas the pure PEG esters form hexagonal and cubic mesophases. The ability of Gelucire 50/13 to yield NLC was evaluated by using Precirol ATO 5 as a model solid lipid and various.

Inert material derived from hydrogenated food-grad oils & fats;. Scanning electron microscopy analysis showed that it was possible to obtain spherically shaped and nonaggregated microparticles;. A strategy to enhance drug release and trypanocidal activity.

The vibrational behavior of the mixture quercetin/Gelucire 50/13 at room and body temperature. It is available in pellet form. Enhancement of dissolution and in vivo evaluation of lornoxicam ternary system with Gelucire 50/13 and polysorbate 80.

12 In a previous work, it was investigated the use of Gelucire 39/01 as a controlled release agent, in combination with the hydrophilic gelling polymer hydroxypropyl methylcellulose (HPMC K15M) and with sodium cross-linked carboximethylcellulose (Carmacel). Vibrational behavior of Gelucire in the spectral range 1800–1000 cm −1 at T = 24 °C. Physical characterization As Gelucire® 44/14 is a semi-solid crystalline excipient, formulators should characterize the structure of the mixture containing this lipid-basedvehicleand thedrug substanceto ascer-tain that their formulation is in its most stable formand retains itsself-emulsifying properties.

Gelucires containing only polyethylene glycol (PEG) esters (Gelucire 55/18) are generally used in the preparation of fast-release formulations, while Gelucires containing only glycerides or a mixture of glycerides and PEG esters (Gelucire 54/02, 50/13, 43/01) are used in the preparation of sustained-release formulations (17,18). Present study, the in vitro dissolution showed. Gelucire ® 50/13 structure is mainly imposed by.

You can also browse global suppliers,vendor,prices,Price,manufacturers of Gelucire 50-13(-05-8). Ethyl cellulose, methylcellulose, and. People make our name.

Gelucire series of lipids from Gattefossé) are PEG containing mixtures of acylglycerides:. Gelucire 50/13 (G50/13) was assessed to develop controlled release formulation of salbutamol sulphate (SBL) a highly water soluble drug by semisolid matrix filling capsule technique. 4), diffractograms of physical mixtures are simply the sum of those of pure components in all cases while the intensity of the peaks of IND diminished with the increase in polymer ratio in case of SDs.

Jammula S et al. The Gelucire 50/13 used as sustained release matrix forming agent in pharmaceutical applications and it have demonstrated the ability to improve the dissolution as well as the absorption of poorly. Self-emulsifies in aqueous fluid.

In case of IND–Gelu. Worldwide USA China India EMAIL INQUIRY to 9 suppliers. The solid state characterization using scanning electron microscopy and X-ray powder diffraction, indicated that the drug was homogeneously distributed in the.

Contrary to SD of PEG, the IND peaks remained viewed in higher ratio of polymer (1:4). Gelucire 50/13 was essentially studied by Raman and IR spectroscopies according to the temperature and the degree of hydration. A solid dispersion of Meloxicam (MX), a poorly soluble, non steroidal anti-inflammatory drug, and Gelucire 50/13 was prepared by spray drying.

• These modes in this spectral range are very sensitive to environmental changes. Chemicalbook is a platform dedicated to provide the most valuable resources for chemical industry users. R=C16 or C18 Schematic structures PEG1500 esters O H R -C O -O 3 3 O -C O -R R -C O -O 3 3 Phospholipon® 90G Phospholipon® 90G was received as a gift sample from Phospholipid GmbH (Nattermannalle, Germany).

The presence of. GELUCIRE 50-13 (CAS No. ChemicalBook provide Chemical industry users with Gelucire 50-13 Boiling point Melting point,Gelucire 50-13 Density MSDS Formula Use,If You also need to Gelucire 50-13 Other information,welcome to contact us.

How to say Gelucire in English?. Drug,gelucire 50/13 and microcrystalline cellulose in aweight ratio of 1:5:10, was markedly rapid and higher than that from the drug powder and the market product (Afinitor®, Novartis Pharmaceuti-cals) in all dissolution mediums tested from pH 3.0 to pH 6.8.